| Name | Title | Contact Details |
|---|---|---|
Nadia Owens |
SVP Total Rewards | People & Culture | Profile |
Karen Alexander |
Vice President of Human Resources | Profile |
Rosemary Collazo |
Vice President for CWBH Support Teams | Profile |
Grembowiec and Associates Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
GGB Industries Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Columbia is a census-designated place in Howard County, Maryland, United States, and is one of the principal communities of the Baltimore–Washington metropolitan area.
We`re out to change the course of medical science. Are you ready to rise to the challenge? Premier Research is not about being everything to everyone. Instead, our deep, focused expertise targets the therapeutic areas and indications where today`s biotech and specialty pharma pioneers are doing the most amazing work. We`re 1,000 employees strong and operate in more than 20 countries, delivering unmatched expertise, operational skills, and dedication to meeting customers` most challenging needs. Join us and meet some of the brightest minds in clinical development today — people who apply their best thinking to every project, recognizing that what they do significantly affects the lives and well-being of customers, patients, physicians, and colleagues. You`ll enjoy great benefits and very flexible working conditions in a company that values your contributions, rewards your achievements, and is committed to helping you reach your full potential.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.